Outcomes of Ab Interno 63 µm vs. 45 µm XEN® Gel Stent in Open-Angle Glaucoma: A Five-Year Follow-Up Study
Journal of Clinical Medicine · 15.04.2026 · 15 (8) · 3028
DOI: 10.3390/jcm15083028 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 15.04.2026. Verfasst von Thomas Jacobs und 7 weiteren Autor:innen. Beteiligte Einrichtung: Research Group Ophthalmology, Department of Neurosciences, KU Leuven, 3000 Leuven, Belgium. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background/Objectives: To compare the five-year efficacy and safety of the 63 µm (XEN63) vs. 45 µm (XEN45) XEN® Gel Stent in patients with open-angle glaucoma (OAG).
Methods
This retrospective matched (1:1) cohort study included adults with OAG who underwent standalone ab interno implantation of the XEN63 or the XEN45 between 2014 and 2021 at a tertiary referral center in Belgium. The primary outcome was IOP at five years. The secondary outcomes included surgical success, topical medication use, postoperative hypotony, complications and interventions.
Results
Thirty eyes of 30 patients (15 XEN63 and 15 XEN45) were analyzed. The baseline characteristics were comparable. At five years, the mean IOP did not differ between the XEN63 and the XEN45 (11.5 vs. 11.0 mmHg; p = 0.54). The XEN63 demonstrated higher complete success rates than the XEN45 for both the IOP < 18 mmHg (10 vs. four eyes; p = 0.016) and
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Research Group Ophthalmology, Department of Neurosciences, KU Leuven, 3000 Leuven, Belgium.
- Department of Ophthalmology, University Hospitals UZ Leuven, 3000 Leuven, Belgium.
- Centre for Eye Research Australia, East Melbourne, VIC 3002, Australia.
- Royal Victorian Eye and Ear Hospital, East Melbourne, VIC 3002, Australia.
- Ophthalmology, Department of Surgery, University of Melbourne, Melbourne, VIC 3010, Australia.
ORCID-Profile: Thomas Jacobs, Victor Raeymaeckers, Nathan M Kerr, Keith R Martin, Jan Van Eijgen, Ingeborg Stalmans
Zitieren
APA
Jacobs, T., Billen Moulin-Romsée, M. I., Raeymaeckers, V., Faizi, N., Kerr, N. M., Martin, K. R., Eijgen, J. V., & Stalmans, I. (2026). Outcomes of Ab Interno 63 µm vs. 45 µm XEN® Gel Stent in Open-Angle Glaucoma: A Five-Year Follow-Up Study. Journal of Clinical Medicine, 15(8), 3028. https://doi.org/10.3390/jcm15083028
Vancouver
Jacobs T, Billen Moulin-Romsée MI, Raeymaeckers V, Faizi N, Kerr NM, Martin KR, et al. Outcomes of Ab Interno 63 µm vs. 45 µm XEN® Gel Stent in Open-Angle Glaucoma: A Five-Year Follow-Up Study. Journal of Clinical Medicine. 2026;15(8):3028. doi:10.3390/jcm15083028
BibTeX
@article{Jacobs2026,
author = {Jacobs, Thomas and Billen Moulin-Romsée, Marie-Isaline and Raeymaeckers, Victor and Faizi, Nawid and Kerr, Nathan M and Martin, Keith R and Eijgen, Jan Van and Stalmans, Ingeborg},
title = {Outcomes of Ab Interno 63 µm vs. 45 µm XEN® Gel Stent in Open-Angle Glaucoma: A Five-Year Follow-Up Study},
journal = {Journal of Clinical Medicine},
year = {2026},
volume = {15},
number = {8},
pages = {3028},
doi = {10.3390/jcm15083028}
}
EUVIMED